pharmaceuticals

Samsung to Invest USD 22 Billion on AI, 5G and Biopharmaceuticals

Samsung to Invest USD 22 Billion on AI, 5G and Biopharmaceuticals

Samsung plans to spend USD 22 Billion in the next three years on developing artificial intelligence, 5G, automotive electronic parts and biopharmaceuticals. This comes as part of the earlier announced USD 160 Billion investment on research, developm..

Valeant Pharmaceuticals Posted Q4 Earnings

Valeant Pharmaceuticals Posted Q4 Earnings

On Wednesday, Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced its financial results for the fourth quarter of 2017. With revenue missing estimates and earnings beating estimates, shares of the company dropped 9% to $16.84 per share..

Regeneron Pharma beats Q3 earnings

Regeneron Pharma beats Q3 earnings

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third quarter earnings for fiscal year 2017 and beat analysts’ estimates, sending shares up almost 7 percent shortly after open on Wednesday.For the third quarter, Regeneron reported r..

Johnson & Johnson's Q3 Earnings Drop but Beat Estimates

Johnson & Johnson's Q3 Earnings Drop but Beat Estimates

On Tuesday, Johnson & Johnson (NYSE: JNJ) announced its financial results for the third quarter of 2017. The company also adjusted its guidance for full-year 2017 in the statement on Tuesday.For the third quarter of 2017, the company announced s..

National Institute of Health partners with 11 Biopharma companies for Cancer Research

National Institute of Health partners with 11 Biopharma companies for Cancer Research

The National Institutes of Health and 11 biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT). This is a five-year-public-private research collaboration totaling $215 million as part of the Cancer Moons..

Alnylam Pharmaceuticals Stock Jumps After Positive Phase 3 Trial Results

Alnylam Pharmaceuticals Stock Jumps After Positive Phase 3 Trial Results

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares jumped more than 40% after the pharma company, together with Sanofi Genzyme, the specialty care global business unit of Sanofi, announced that the APOLLO Phase 3 study of patisiran, an investigatio..

Valeant Pharmaceuticals Announced Q2 Earnings, Shares Jumped

Valeant Pharmaceuticals Announced Q2 Earnings, Shares Jumped

On Tuesday, Valeant Pharmaceuticals Intl Inc (NYSE: VRX) announced its financial results for the second quarter. With earnings beating estimates, shares of the company increased 7.6% to $16.54 per share in morning trading on Tuesday after the announ..